Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death.
J Exp Med (1996) 184 (5): 2067–2072.
Currently there are no citedby results. Try again later.
